Transforming growth factor β inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at serine 795
- 30 April 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (4) , 605-614
- https://doi.org/10.1016/s0301-472x(99)00004-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.The Journal of Experimental Medicine, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- Transforming growth factor‐β: A bidirectional regulator of hematopoietic cell growthThe International Journal of Cell Cloning, 1992
- Transforming growth factor β inhibits the action of stem cell factor on mouse and human hematopoietic progenitorsThe International Journal of Cell Cloning, 1992
- Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylationCell, 1990
- Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic featuresBritish Journal of Haematology, 1988
- Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cellsNature, 1987
- Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth FactorScience, 1984
- HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin ExpressionScience, 1982
- Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating ActivityScience, 1978